Cite
HARVARD Citation
Wang, Z. et al. (2019). A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). European journal of cancer. pp. 183-191. [Online].